139 results on '"Islam, Imadul"'
Search Results
2. Comparative performance of liquid chromatography and spectrophotometry in determining metformin hydrochloride within pharmaceutical formulations
3. An insight into the biological activity and structure-based drug design attributes of sulfonylpiperazine derivatives
4. Discovering biological efficacy of new thiadiazole as effective inhibitors of urease, glycation, and (DPPH) scavengers: Biochemical and in silico study
5. Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors
6. Solar-Powered Molecular Crystal Motor Based on an Anthracene-Thiazolidinedione Photoisomerization Reaction.
7. Synthesis, Characterization, In Silico DFT, Molecular Docking, and Dynamics Simulation Studies of Phenylhydrazono Phenoxyquinolones for Their Hypoglycemic Efficacy
8. Solar-Powered Molecular Crystal micro-Motor Based on an Anthracene-Thiazolidinedione Photoisomerization Reaction
9. Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study.
10. Determination of Voriconazole in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry: Application in Therapeutic Drug Monitoring
11. A Comparative Study of Different Analytical Methods for the Analysis of Metformin Hydrochloride in Pharmaceutical Formulation
12. Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study
13. Effect of Fluorination on the Polymorphism and Photomechanical Properties of Cinnamalmalononitrile Crystals
14. Photochemical Synthesis of (2E,4Z)-5-(anthracen-9-yl)-2-cyanopenta-2,4-dienamide
15. Distinct Mechanisms of Cytotoxicity in Novel Nitrogenous Heterocycles: Future Directions for a New Anti-Cancer Agent
16. Synthesis of new urease enzyme inhibitors as antiulcer drug and computational study.
17. Synthesis of new urease enzyme inhibitors as antiulcer drug and computational study
18. Novel P2Y 12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): In vitro effects on platelets
19. Effect of halogen substitution on energies and dynamics of reversible photomechanical crystals based on 9-anthracenecarboxylic acid
20. Molecular Crystal Microcapsules: Formation of Sealed Hollow Chambers via Surfactant‐Mediated Growth
21. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
22. KAIMRC’S Second Therapeutics Discovery Conference
23. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis
24. Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process
25. BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder
26. Therapeutics discovery: From bench to first in-human trials*
27. Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase
28. Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder
29. ChemInform Abstract: Discovery of Potent and Selective Small Molecule NPY Y5 Receptor Antagonists.
30. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX- 517
31. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: Design, synthesis and biological activity
32. 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa)
33. Structures of potent selective peptide mimetics bound to carboxypeptidase B
34. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): In vitro effects on platelets
35. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) – Part II: Enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis
36. A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) – Part I: Pharmacological characterization
37. A novel P2Y12 adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models
38. The key role of water in the heterogeneous permanganate oxidation of $\omega$-hydroxy alkenes
39. Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8
40. Discovery of potent and selective small molecule NPY Y5 receptor antagonists
41. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model
42. A Non-peptide Functional Antagonist of the CCR1 Chemokine Receptor Is Effective in Rat Heart Transplant Rejection
43. Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1
44. Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y 5 receptor antagonists
45. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor
46. Discovery of Novel Non-Peptide CCR1 Receptor Antagonists
47. Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor
48. The Organic Chemistry of the Pyrrolo[1,2-a]benzimidazole Antitumor Agents. An Example of Rational Drug Design
49. Pyrrolo[1,2-a]benzimidazole-Based Quinones and Iminoquinones. The Role of the 3-Substituent on Cytotoxicity
50. Structure-activity studies of benzimidazole-based DNA-cleaving agents. Comparison of benzimidazole, pyrrolobenzimidazole, and tetrahydropyridobenzimidazole analogs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.